By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ImmunoGen, Inc. 

128 Sidney Street

Cambridge  Massachusetts  02139-4239  U.S.A.
Phone: 617-995-2500 Fax: 617-995-2510


SEARCH JOBS




Collaborations

GlaxoSmithKline (North Carolina) 

Raven Biotechnologies, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.

Medarex, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.





Company News
ImmunoGen (IMGN) CEO Sees Potential in Company‚Äôs Lead ADC Product 1/18/2017 6:50:25 AM
ImmunoGen (IMGN) Announces Mirvetuximab Soravtansine Phase 1 Expansion Cohort Results In Platinum-Resistant Ovarian Cancer Published In The Journal Of Clinical Oncology 12/28/2016 9:03:02 AM
ImmunoGen (IMGN) Release: Preclinical Data On IMGN632, A Novel CD123-Targeting ADC, Presented At American Society of Hematology Annual Meeting 12/6/2016 11:37:21 AM
ImmunoGen (IMGN) To Present Preclinical Data Highlighting Potential Of Combining Mirvetuximab Soravtansine With An Immune Checkpoint Inhibitor At SITC 2016 Annual Meeting 11/11/2016 11:45:56 AM
ImmunoGen (IMGN) Reports Financial Results For Quarter Ended September 30 And Reviews Business Highlights 10/28/2016 12:26:47 PM
ImmunoGen (IMGN) Announces Conference Call To Discuss Its Financial Results For Quarter Ended September 30 10/14/2016 12:13:28 PM
Struggling ImmunoGen (IMGN) Eliminates 17% of Workforce After Strategic Review 9/30/2016 5:46:52 AM
ImmunoGen (IMGN) Announces Departure Of Chief Development Officer 8/9/2016 11:15:38 AM
ImmunoGen (IMGN) Announces Webcasts Of Presentations At Upcoming Investor Conferences 8/5/2016 11:25:58 AM
ImmunoGen (IMGN) Reports Fourth Quarter And Fiscal Year 2016 Financial Results And Provides Quarterly Business Update 8/4/2016 12:08:03 PM
12345678910...
//-->